Syngene International Ltd vs Wardwizard Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Syngene International Ltd is ₹ 397.4 as of 30 Oct 11:21 . The P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 yearsThe P/E Ratio of Wardwizard Healthcare Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 yearsThe Market Cap of Wardwizard Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Syngene International Ltd for the Sep '26 is ₹ 860.7 crore as compare to the Jun '26 revenue of ₹ 761.3 crore. This represent the growth of 13.06% The revenue of Wardwizard Healthcare Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Syngene International Ltd for the Sep '26 is ₹ 168.7 crore as compare to the Jun '26 ebitda of ₹ 102.6 crore. This represent the growth of 64.42% The ebitda of Wardwizard Healthcare Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ 32.2 crore over 10 quarters. This represents a CAGR of -28.96% The net profit of Wardwizard Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 yearsThe Dividend Payout of Wardwizard Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

About Wardwizard Healthcare Ltd

Wardwizard Healthcare Limited was erstwhile incorporated as 'Ayoki Merchantile Limited' on January 3, 1985.
The Company name was changed from 'Ayoki Merchantile Limited' to 'Wardwizard Healthcare Limited' on December 11, 2023.
Initially, Company engaged in the trading of Consumer Goods and Services, providing Advisory, Consultancy, Investments Services. In 2019-20, the Company changed its object by inserting some new objects in the Main object clause of Memorandum of Association of the Company by taking members approval.
The Board started working on the different division of Business to begin with the operations of Company which can benefit to the Company and its stakeholders as well. In 2023-24, the open offer for the acquisition of 1,47,000 fully paid-up equity shares at an offer price of Rs.

FAQs for the comparison of Syngene International Ltd and Wardwizard Healthcare Ltd

Which company has a larger market capitalization, Syngene International Ltd or Wardwizard Healthcare Ltd?

Market cap of Syngene International Ltd is 16,251 Cr while Market cap of Wardwizard Healthcare Ltd is 1 Cr

What are the key factors driving the stock performance of Syngene International Ltd and Wardwizard Healthcare Ltd?

The stock performance of Syngene International Ltd and Wardwizard Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Syngene International Ltd and Wardwizard Healthcare Ltd?

As of October 31, 2026, the Syngene International Ltd stock price is INR ₹402.6. On the other hand, Wardwizard Healthcare Ltd stock price is INR ₹45.34.

How do dividend payouts of Syngene International Ltd and Wardwizard Healthcare Ltd compare?

To compare the dividend payouts of Syngene International Ltd and Wardwizard Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.